Patients who achieved pathological complete response (pCR) after neoadjuvant therapy showed a trend toward improved survival, though not statistically significant HR = 0.83 (95% CI: 0.48–1.41, p = 0.483).
← all excerpts
Clinical characteristics and prognostic impact of HER2 low expression in breast cancer subtypes from a Brazilian real-world cohort.
1
—
—